Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

NCT03725007 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03725007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03725007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 24, 2019
Completion date
March 31, 2029
Enrollment
124 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis (jia)